These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9338482)

  • 1. The potential management of resistant infections with non-antibiotics.
    Kristiansen JE; Amaral L
    J Antimicrob Chemother; 1997 Sep; 40(3):319-27. PubMed ID: 9338482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenothiazines as a solution for multidrug resistant tuberculosis: From the origin to present.
    Kristiansen JE; Dastidar SG; Palchoudhuri S; Roy DS; Das S; Hendricks O; Christensen JB
    Int Microbiol; 2015 Mar; 18(1):1-12. PubMed ID: 26415662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial properties of methdilazine and its synergism with antibiotics and some chemotherapeutic agents.
    Chattopadhyay D; Dastidar SG; Chakrabarty AN
    Arzneimittelforschung; 1988 Jul; 38(7):869-72. PubMed ID: 2905130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity of nonantifungal drugs.
    Afeltra J; Verweij PE
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):397-407. PubMed ID: 12884072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial genetics, antibiotic usage, and public policy: the crucial interplay in emerging resistance.
    Fekete T
    Perspect Biol Med; 1995; 38(3):363-82. PubMed ID: 7746716
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis.
    Vesenbeckh S; Krieger D; Bettermann G; Schönfeld N; Bauer TT; Rüssmann H; Mauch H
    Tuberculosis (Edinb); 2016 May; 98():27-9. PubMed ID: 27156615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications.
    Sharma S; Singh A
    Expert Opin Investig Drugs; 2011 Dec; 20(12):1665-76. PubMed ID: 22014039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria.
    Dastidar SG; Kristiansen JE; Molnar J; Amaral L
    Antibiotics (Basel); 2013 Feb; 2(1):58-72. PubMed ID: 27029292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of resistance in microorganisms by help of non-antibiotics.
    Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H
    J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of the newer beta-lactam antibiotics.
    Turck M
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():45-62. PubMed ID: 3062004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of vancomycin activity by phenothiazines against vancomycin-resistant Enterococcus faecium in vitro.
    Rahbar M; Mehrgan H; Hadji-nejad S
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):676-9. PubMed ID: 20353486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections.
    Mansour SC; de la Fuente-Núñez C; Hancock RE
    J Pept Sci; 2015 May; 21(5):323-9. PubMed ID: 25358509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
    Kahan F; Kropp H
    Immun Infekt; 1986 Nov; 14(6):232-5. PubMed ID: 3100429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?
    Hathorn JW; Pizzo PA
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():41-54. PubMed ID: 3519563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present status and prospect of developing antibiotics against drug resistant gram negative bacilli].
    Umezaula H
    Nihon Rinsho; 1977; 35(3):1409-12. PubMed ID: 559129
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacteria outwit us].
    Ajanki T
    Vardfacket; 1998 Jan; 22(1):32-4. PubMed ID: 9528635
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antimicrobial peptides: a new way to treat bacterial infections].
    Igaz P
    Orv Hetil; 2001 Jan; 142(4):169-71. PubMed ID: 11232153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB.
    Amaral L; Martins A; Molnar J; Kristiansen JE; Martins M; Viveiros M; Rodrigues L; Spengler G; Couto I; Ramos J; Dastidar S; Fanning S; McCusker M; Pages JM
    In Vivo; 2010; 24(4):409-24. PubMed ID: 20668307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
    Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.
    Amaral L; Viveiros M
    Int J Antimicrob Agents; 2012 May; 39(5):376-80. PubMed ID: 22445204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.